| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/08/2008 | WO2007146856A3 Substituted gamma lactams as therapeutic agents |
| 05/08/2008 | US20080108702 Use of Acetyl-Leucine for Preparing a Drug for Treating Balance Disorders |
| 05/08/2008 | US20080108579 macrolide or macrolide analog such tacrolimus, sirolimus, everolimus, pimecrolimus as is administered to a post-ocular surgery patient to reduce or minimize ocular scarring |
| 05/08/2008 | US20080107738 Ophthalmic Emulsions Containing Prostaglandins |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107714 Use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the treatment of corneal neovascularization |
| 05/08/2008 | US20080107694 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders |
| 05/08/2008 | US20080107677 Culture filtrate concentrate from Basidiomycetes; Parkinson's disease; diabetes |
| 05/08/2008 | US20080107644 Pai-1 binding modulators for the treatment of ocular disorders |
| 05/08/2008 | US20080107603 Administering L-ergothioneine; Alzheimer's disease, multiple sclerosis, stroke, traumatic brain injury, spinal cord injuries |
| 05/08/2008 | CA2667997A1 Humanized anti-factor d antibodies and uses thereof |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1917964A1 Percutaneously absorbable ophthalmic preparation |
| 05/07/2008 | EP1917239A1 Fluoroprostaglandins nitroderivatives |
| 05/07/2008 | EP1729785B1 Eye drops consisting of filtered clayey water for treating glaucoma |
| 05/07/2008 | EP1722795B1 Piperidinyl prostaglandin e analogs |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
| 05/07/2008 | EP1141306B1 Streptococcus antigens |
| 05/07/2008 | EP0918529B1 Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
| 05/07/2008 | CN101175496A Prostaglandin F2a derivative inclusion product |
| 05/07/2008 | CN101175487A Prophylactic or curative agent for keratoconjunctive disorder |
| 05/07/2008 | CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/07/2008 | CN100386091C Medicine for treating canker and preparing method |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368450 Sodium channel blockers |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | CA2376780C Intraocular tension lowering compositions for topical administration |
| 05/06/2008 | CA2310230C The use of brinzolamide to prevent visual field loss |
| 05/02/2008 | WO2008052145A2 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 05/02/2008 | WO2008052143A2 Mixing device and output fluids of same |
| 05/02/2008 | WO2008050896A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 05/02/2008 | WO2008050866A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 05/02/2008 | WO2008050776A1 Ophthalmic aqeous liquid preparation |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008032222A3 Treatment of vertigo with acetyl-l-leucine |
| 05/02/2008 | WO2007144621A3 Protection against and treatment of age related macular degeneration |
| 05/02/2008 | WO2007119600A9 Carbazole compound |
| 05/02/2008 | CA2667536A1 Highly purified type a botulinum toxin preparation from infant botulism pathogen |
| 05/02/2008 | CA2665024A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 05/01/2008 | US20080103211 Poly(divinylbenzene-styrene)sulfonic acid and levobetaxolol; glaucoma |
| 05/01/2008 | US20080103198 2-chlorophenyl-2-hydroethyl-carbamate; neuroprotective agent; otoprotection from damage to neural tissue and cells of the mammalian inner ear from neural injury or insult and from neurotoxic or ototoxic agents; loss of hearing and balance impairments |
| 05/01/2008 | US20080103153 Combination of brimonidine and timolol for topical ophthalmic use |
| 05/01/2008 | US20080102101 Enhanced recovery following ocular surgery |
| 05/01/2008 | US20080102099 comprising: a viscoelastic solution comprising hyaluronic acid (HA); a drug selected from the group consisting of a steroid drug, quinolone, a non-steroid anti-inflammatory drug, an immunosuppressant and a drug that is compatible with the implant; and chitosan |
| 05/01/2008 | US20080102090 Mixture with surfactant; therapy for muscular paralysis; greater intramuscular safety margin; selective action on inhibition of pain-related (nociceptive) nerve cell function |
| 05/01/2008 | US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |
| 04/30/2008 | EP1915998A1 Prophylactic or therapeutic agent for corneal/conjunctival disease |
| 04/30/2008 | EP1915996A1 Agents for treating intraocular inflammation caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives |
| 04/30/2008 | EP1915993A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/30/2008 | EP1586316B1 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/30/2008 | CN101171030A Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 04/30/2008 | CN101168014A Traditional Chinese medicine for treating exudative otitis media |
| 04/30/2008 | CN101167983A Traditional Chinese medicine for treating eye hidden and acerbity type dacryocystitis |
| 04/30/2008 | CN101167966A Traditional Chinese medicine formula for treating acute central retinitis |
| 04/30/2008 | CN101167964A Traditional Chinese medicine formula for treating achromatopsia |
| 04/30/2008 | CN101167954A Traditional Chinese medicinal preparation for improving middle-aged and old people eye diseases and preparation method thereof |
| 04/30/2008 | CN101167935A Traditional Chinese medicine for treating herpetic stromal keratitis |
| 04/30/2008 | CN101167927A Traditional Chinese medicine formula for treating eye and face spasm |
| 04/30/2008 | CN101167917A Traditional Chinese medicine for treating aural vertigo |
| 04/30/2008 | CN101167890A Traditional Chinese medicine for treating superficial punctuate keratitis |
| 04/30/2008 | CN101167884A Orally-administered traditional Chinese medicinal formula for treating cataract |
| 04/30/2008 | CN101167866A Orally-administered traditional Chinese medicinal composition for treating purulent tympanitis |
| 04/30/2008 | CN101167852A Traditional Chinese medicine for treating keratitis caused by red eye and heat pain |
| 04/30/2008 | CN101167845A Traditional Chinese medicine for treating infantile blinking |
| 04/30/2008 | CN101167825A Traditional Chinese medicine for treating infantile tympanitis |
| 04/30/2008 | CN101167713A Chloromycetin eyedrops with good stability and preparation method thereof |
| 04/30/2008 | CN101167712A Chloromycetin eyedrops and preparation method thereof |
| 04/30/2008 | CN101167711A Chloromycetin eyedrops and preparation method thereof |
| 04/30/2008 | CN101167710A Chloromycetin eyedrops with long quality guaranteed period and preparation method thereof |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384844C Xanthine phosphodiesterase V inhibitor polymorphs |
| 04/30/2008 | CN100384838C Novel benzylpiperidine compound |
| 04/30/2008 | CN100384827C Ophthalmic compositions for treating ocular hypertension |
| 04/30/2008 | CN100384480C Delivery system for nucleic acids |
| 04/30/2008 | CN100384430C Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 04/30/2008 | CN100384417C Pyranoindazoles and their use for the treatment of glaucoma |
| 04/30/2008 | CN100384408C Novel composition |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
| 04/29/2008 | CA2297732C Heterocyclic vinylethers against neurological disorders |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/24/2008 | WO2008049043A2 Ophthalmic compositions comprising diglycine |
| 04/24/2008 | WO2008048577A1 Methods of using 4-phenylaminoquinolines as topical non-steroidal antiinflammatory compounds |
| 04/24/2008 | WO2008048134A1 Pharmaceutical compositions for preventing and treating eye pathologies |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
| 04/24/2008 | WO2008046882A2 Composition comprising an nk-1 receptor antagonist and an ssri for the treatment of tinnitus and hearing loss |
| 04/24/2008 | WO2008046598A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/24/2008 | WO2008046228A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | WO2008024765A3 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 04/24/2008 | WO2007011874A3 Formulation and method for administration of ophthalmologically active agents |